Key points
- Tyler Shultz warns the AI boom is a great opportunity to deceive people, mirroring Theranos.
- Shultz states investor due diligence must evolve beyond informal meetings and large cash injections.
- The Theranos case resurfaces as AI companies raise massive capital without proven profitability.
Tyler Shultz, a key whistleblower in the Theranos scandal, warned that the current artificial intelligence boom presents a significant opportunity for deception. In an interview with The San Francisco Standard, Shultz drew parallels between the flawed blood-testing company and today’s AI sector, where firms achieve trillion-dollar valuations despite never turning a profit.
The claim
Shultz argued that the era of investors handing over large sums after brief, informal interactions should end. He noted that Elizabeth Holmes scaled this model to raise massive amounts, describing Theranos’ fundraising as potentially the largest angel round in history. He emphasized that giving such power to founders without rigorous oversight allows for significant misuse of capital and influence.
The response
The recent documentary “You Can See Everything,” directed by Nathan Fielder and Lance Oppenheim, has reignited public interest in Holmes’ case. The film highlights Holmes’ ability to garner sympathy even from those aware of her crimes. Shultz observed that the renewed media attention serves Holmes’ interests, stating that she wants people to discuss her legacy now that her legal case is closed and she is in federal prison.
Why this matters now
Theranos reached a peak valuation of approximately $10 billion despite its core technology never functioning correctly.reported The company used its own machines for only a fraction of tests, outsourcing the rest to third-party equipment. Shultz’s comments arrive as the AI industry experiences a surge in capital inflows, raising questions about whether similar valuation disconnects could occur in this new technological landscape.
Evidence: reported
Theranos whistleblower Tyler Shultz warns that the AI boom is ‘a great opportunity to go deceive people’aifleet-techcrunch
What buyers should weigh
Shultz believes investors need to recognize that providing large sums of money gives founders tremendous power. He stated that the days of having a thirty-minute coffee and sending money should be over. The source material does not provide specific guidance for enterprise IT buyers regarding vendor selection or cost analysis. Uncertainty remains regarding how these investment warnings translate to enterprise procurement decisions.
Why it matters
- Shultz warns that the AI boom is a great opportunity to deceive people, similar to the Theranos case.
- Theranos raised capital at a $10 billion valuation despite its technology never actually working.
- Shultz believes investors give tremendous power to founders when they provide large amounts of money.
- The source notes that Theranos’ funding often came from individual investors rather than venture firms.
Topics: AI ethics, venture capital, Theranos, vendor risk, due diligence
Updated
Ask the article
Local keyword search of this article; no generated answers.Did this article give you the evidence you needed?
Your choice stays on this device. No public tally.Questions readers ask
What specific warning did Tyler Shultz give about the AI industry?
Shultz warned that the AI boom is a great opportunity to deceive people, comparing current valuation trends to the Theranos scandal.
How did Theranos fund its operations despite non-functional technology?
Theranos raised massive capital, potentially the largest angel round ever, from individual investors and families rather than traditional venture firms.
What role did third-party equipment play in Theranos' testing?
Theranos used its own machines for only a fraction of tests, outsourcing the majority to third-party equipment to produce results.
Connected stories
Reading receipt
- Tyler Shultz warns the AI boom is a great opportunity to deceive people, mirroring Theranos.
- Shultz states investor due diligence must evolve beyond informal meetings and large cash injections.
- The Theranos case resurfaces as AI companies raise massive capital without proven profitability.
